Agrinetica leverages CRISPR 2.0 - the cutting-edge advancement beyond Nobel Prize-winning gene-editing technology - to deliver practical, high-impact traits for the $100 billion peanut industry.
Agrinetica is a global pioneer in applying advanced CRISPR 2.0 tools to peanuts, creating next-generation varieties that reduce allergenicity, extend shelf-life, boost climate resilience, and protect yields.
Our gene-edited traits are designed to fit non-GMO regulatory definitions in key markets while solving the industry's five critical challenges.
Creating the world's first allergen-reduced, healthier, higher quality peanuts with improved yields that consumers embrace, and climate resilience that benefits growers - proving that the future of peanuts is here today.
Our compact CRISPR 2.0 tools are at least 50% smaller than first-generation CRISPR, enabling us to: Apply CRISPR across all crops with ease Accelerate development and reduce costs by over 50% The result: Products that solve real problems while aiming to avoid being classified as traditional GMOs in markets like the U.S. and to achieve much broader consumer acceptance.
Our scientific leadership brings expertise in peanut genetics, transformation, and trait development.
Reduced-allergen varieties already growing in our fields
Addressing up to 30% of crop losses through synchronized pod development
Months longer freshness through optimized fatty acid profiles
Preventing aflatoxin contamination through uniform maturation of pods
Protecting 40% of vulnerable growing regions
Operating within one of the world's leading agricultural genome-editing companies accelerates our regulatory approvals, field trials, and global commercialization.
Years ahead in development, patents, and regulatory pathways.
Evidence-driven
Grower-focused
Safety-first
Value-oriented
Every trait we develop must deliver measurable field performance and clear economic benefits across the entire value chain.
World-class experts translating breakthrough science into market reality

Chairman

CEO & Co-founder

Director

CFO & HR

VP R&D

CTO and Co-founder

Scientific Advisor

Scientific Advisor

Virology Advisor

Breeding & Genetics Advisor